Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. (DMAQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMAQ · as of Jun 9, 2026
Key Statistics
Explore Deep Medicine Acquisition Corp. Data
dmaq stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dmaq competitorsDMAQ
ACAC
AFTR-UN
AHRN
ALOR
AOAOStock Performance
Full HistoryAbout Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, …
what is deep medicine acquisition corp. · dmaq stock overview · deep medicine acquisition corp. company profile · who is deep medicine acquisition corp. ceo · dmaq NASDAQ · deep medicine acquisition corp. headquarters · deep medicine acquisition corp. business segments
About Stock Overview & Key Data
Deep Medicine Acquisition Corp. (DMAQ) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Dec 2, 2021. As of the latest trading session, DMAQ stock price is $2.96, with a market capitalization of $12.9M. The stock has returned -71.54% over the past 12 months and -74.61% year-to-date.
In fiscal year 2026, Deep Medicine Acquisition Corp. reported revenue of $18.9M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Deep Medicine Acquisition Corp. (DMAQ) stock price is $2.96. The stock is traded on NASDAQ under the ticker symbol DMAQ. The 52-week range is $2.96 – $19.91.